These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12183069)

  • 1. Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy.
    Zacharski LR
    Cancer Lett; 2002 Dec; 186(1):1-9. PubMed ID: 12183069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of current and emerging antithrombotics in thrombosis and cancer.
    Mousa SA
    Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways of coagulation/fibrinolysis activation in malignancy.
    Zacharski LR; Wojtukiewicz MZ; Costantini V; Ornstein DL; Memoli VA
    Semin Thromb Hemost; 1992 Jan; 18(1):104-16. PubMed ID: 1574711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy as a solid-phase coagulopathy: implications for the etiology, pathogenesis, and treatment of cancer.
    Zacharski LR
    Semin Thromb Hemost; 2003 Jun; 29(3):239-46. PubMed ID: 12888928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer, thrombosis, and anticoagulants.
    Ornstein DL; Zacharski LR
    Curr Opin Pulm Med; 2000 Jul; 6(4):301-8. PubMed ID: 10912637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread.
    Franchini M; Montagnana M; Favaloro EJ; Lippi G
    Semin Thromb Hemost; 2009 Oct; 35(7):644-53. PubMed ID: 20013531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-thrombotics in thrombosis and cancer.
    Mousa SA
    Future Oncol; 2005 Jun; 1(3):395-403. PubMed ID: 16556013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of the coagulation and fibrinolysis system in malignancy: their possible impact on future diagnostic and therapeutic procedures.
    Korte W
    Clin Chem Lab Med; 2000 Aug; 38(8):679-92. PubMed ID: 11071061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
    Rak J; Klement P; Yu J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coagulation system as a target for the treatment of human gliomas.
    Ornstein DL; Meehan KR; Zacharski LR
    Semin Thromb Hemost; 2002 Feb; 28(1):19-28. PubMed ID: 11885022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotics in thrombosis and cancer.
    Mousa SA
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):283-91. PubMed ID: 15030287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological basis of personalized anticoagulation in cancer: oncogene and oncomir networks as putative regulators of coagulopathy.
    D'Asti E; Rak J
    Thromb Res; 2016 Apr; 140 Suppl 1():S37-43. PubMed ID: 27067976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials with anticoagulant and antiplatelet therapies.
    Zacharski LR; Meehan KR; Algarra SM; Calvo FA
    Cancer Metastasis Rev; 1992 Nov; 11(3-4):421-31. PubMed ID: 1423826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo: procoagulant nature of osteosarcoma.
    Ichikawa J; Cole HA; Magnussen RA; Mignemi NA; Butler M; Holt GE; O'Rear L; Yuasa M; Pabla B; Haro H; Cates JM; Hamm HE; Schwartz HS; Schoenecker JG
    Cancer; 2012 May; 118(9):2494-506. PubMed ID: 21953059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulants versus cancer.
    Tieken C; Versteeg HH
    Thromb Res; 2016 Apr; 140 Suppl 1():S148-53. PubMed ID: 27067969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cancer with anticoagulants: rationale in the treatment of melanoma.
    Ornstein DL; Zacharski LR
    Int J Hematol; 2001 Feb; 73(2):157-61. PubMed ID: 11372726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing Tumor Growth and Angiogenesis by Inhibition of Coagulation.
    Nadir Y
    Semin Thromb Hemost; 2019 Sep; 45(6):622-628. PubMed ID: 31398734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulants in thrombosis and cancer: the missing link.
    Mousa SA
    Semin Thromb Hemost; 2002 Feb; 28(1):45-52. PubMed ID: 11885025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood coagulation changes and neoplastic pathology].
    Corsi MP; De Martinis M; Di Leonardo G; Loreto MF; Modesti M; Quaglino D
    Recenti Prog Med; 2000 Oct; 91(10):532-7. PubMed ID: 11072743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.